Please login to the form below
Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?
In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy Watch patient record data, uptake of biosimilars remains relatively muted, with marked inconsistencies across the major European markets. With Enbrel biosimilar Benepali about to launch across EU, we ask what’s next for RA?
http://www.researchpartnership.com/news/2016/04/ft-are-biosimilars-the-answer-to-the-rising-cost-of-...
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Interactive infographic
- Living With: The journey from the patient’s perspective
Research Partnership
- Article: Spotlight on Mexico
- Healthcare under AMLO – One year on
Research Partnership
- News: Mandira Kar joins London Headquarters as Qualitative Research Director
Research Partnership
- Conference Live
- Global medical conferences and events calendar 2020
Research Partnership
- Announcing a change of leadership at the US Philadelphia office
Research Partnership
- Article: Market access in Brazil
- All eyes on Spinraza
Research Partnership
